Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 31 citing articles:

Covid-19 and development of heart failure: mystery and truth
Hope Onohuean, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2021) Vol. 394, Iss. 10, pp. 2013-2021
Open Access | Times Cited: 53
The Potential Role of Growth Differentiation Factor 15 in COVID-19: A Corollary Subjective Effect or Not?
Ahmad O. Babalghith, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Diagnostics (2022) Vol. 12, Iss. 9, pp. 2051-2051
Open Access | Times Cited: 43
Recent Advancements in Computational Drug Design Algorithms through Machine Learning and Optimization
Soham Choudhuri, Manas Yendluri, Sudip Poddar, et al.
Kinases and Phosphatases (2023) Vol. 1, Iss. 2, pp. 117-140
Open Access | Times Cited: 27
SARS‐CoV‐2 induced HDL dysfunction may affect the host's response to and recovery from COVID‐19
Hayder M. Al‐kuraishy, Nawar Raad Hussien, Marwa S. Al‐Niemi, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 20
Arginine vasopressin and pathophysiology of COVID-19: An innovative perspective
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Safaa Qusti, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112193-112193
Open Access | Times Cited: 45
Drug repurposing against SARS-CoV-2 using computational approaches
Sumit Kumar, Svitlana Kovalenko, Shakshi Bhardwaj, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 7, pp. 2015-2027
Open Access | Times Cited: 21
Molecular Docking and Dynamics Simulation Studies Predict Potential Anti-ADAR2 Inhibitors: Implications for the Treatment of Cancer, Neurological, Immunological and Infectious Diseases
Emmanuel Broni, Andrew Striegel, Carolyn Ashley, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6795-6795
Open Access | Times Cited: 13
Anti-Inflammatory and Anti-Rheumatic Potential of Selective Plant Compounds by Targeting TLR-4/AP-1 Signaling: A Comprehensive Molecular Docking and Simulation Approaches
Ashraf Ullah Khan, Shafi Ullah Khan, Adnan Khan, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4319-4319
Open Access | Times Cited: 17
Natural products from Streptomyces spp. as potential inhibitors of the major factors (holoRdRp and nsp13) for SARS-CoV-2 replication: an in silico approach
Prateek Kumar, Parveen, Nafis Raj, et al.
Archives of Microbiology (2024) Vol. 206, Iss. 2
Closed Access | Times Cited: 2
Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19
Melissa Alegría‐Arcos, Tábata Barbosa, Felipe Sepúlveda, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 14
Cytokine storm-calming property of the isoquinoline alkaloids in Coptis chinensis Franch
Yuejia Lan, Huan Wang, Jiasi Wu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 13
Computational Study on Potential Novel Anti-Ebola Virus Protein VP35 Natural Compounds
Louis K. S. Darko, Emmanuel Broni, Dominic S. Y. Amuzu, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1796-1796
Open Access | Times Cited: 17
Consensus docking and MM-PBSA computations identify putative furin protease inhibitors for developing potential therapeutics against COVID-19
Bismark Dankwa, Emmanuel Broni, Kweku S. Enninful, et al.
Structural Chemistry (2022) Vol. 33, Iss. 6, pp. 2221-2241
Open Access | Times Cited: 12
The Significance of COVID-19 Diseases in Lipid Metabolism Pregnancy Women and Newborns
Miljana Z. Jovandarić, Milan Đokić, Ivana Babović, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15098-15098
Open Access | Times Cited: 9
Targeting Leishmania donovani sterol methyltransferase for leads using pharmacophore modeling and computational molecular mechanics studies
Patrick O. Sakyi, Emmanuel Broni, Richard K. Amewu, et al.
Informatics in Medicine Unlocked (2023) Vol. 37, pp. 101162-101162
Open Access | Times Cited: 5
Searching and designing potential inhibitors for SARS-CoV-2 Mpro from natural sources using atomistic and deep-learning calculations
Nguyễn Minh Tâm, Duc-Hung Pham, Đinh Minh Hiệp, et al.
RSC Advances (2021) Vol. 11, Iss. 61, pp. 38495-38504
Open Access | Times Cited: 12
Molecular Modelling and Atomistic Insights into the Binding Mechanism of MmpL3 Mtb
Samuel K. Kwofie, George W. Hanson, Henrietta Sasu, et al.
Chemistry & Biodiversity (2022) Vol. 19, Iss. 9
Closed Access | Times Cited: 8
EBOLApred: A machine learning-based web application for predicting cell entry inhibitors of the Ebola virus
Joseph Adams, Kwasi Agyenkwa-Mawuli, Odame Agyapong, et al.
Computational Biology and Chemistry (2022) Vol. 101, pp. 107766-107766
Closed Access | Times Cited: 8
Molecular modelling and de novo fragment-based design of potential inhibitors of beta-tubulin gene of Necator americanus from natural products
Odame Agyapong, Seth O. Asiedu, Samuel K. Kwofie, et al.
Informatics in Medicine Unlocked (2021) Vol. 26, pp. 100734-100734
Open Access | Times Cited: 9
Inhibitory effect of Sinapic acid derivatives targeting structural and non-structural proteins of dengue virus serotype 2: An in-silico assessment
Miah Roney, Amit Dubey, Normaiza Zamri, et al.
Aspects of Molecular Medicine (2023) Vol. 2, pp. 100028-100028
Open Access | Times Cited: 3
Molecular signaling pathways, pathophysiological features in various organs, and treatment strategies in SARS-CoV2 infection
Yousef Rasmi, Shima Hatamkhani, Roya Naderi, et al.
Acta Histochemica (2022) Vol. 124, Iss. 5, pp. 151908-151908
Open Access | Times Cited: 5
Discovery of druggable potent inhibitors of serine proteases and farnesoid X receptor by ligand-based virtual screening to obstruct SARS-CoV-2
Sumera Zaib, Nehal Rana, Hafiz Saqib Ali, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127379-127379
Closed Access | Times Cited: 2
Diabetic wound healing of aloe vera major phytoconstituents through TGF-β1 suppression via in-silico docking, molecular dynamic simulation and pharmacokinetic studies
Miah Roney, Abdul Rashid Issahaku, Usha Govinden, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-14
Closed Access | Times Cited: 2
Virtual Screening Strategies in Drug Discovery: Potential Inhibitors of Candida Albicans Cytochrome B
xi xu, Shuangkou Chen, Wanhong Zhu, et al.
(2024)
Closed Access
Virtual Screening Strategies in Drug Discovery: Potential Inhibitors of Candida Albicans Cytochrome B
xi xu, Shuangkou Chen, Wanhong Zhu, et al.
(2024)
Closed Access
Page 1 - Next Page

Scroll to top